Cedric Callens

1 Patent

• US116083302023

  Methylamine Derivatives as Lysysl Oxidase Inhibitors for the Treatment of Cancer

  THE INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL

  0 cites